| Kendall Parsons, CNM | |
|
7556 Teague Rd Ste 430, Hanover, MD 21076-1968 | |
| (410) 553-8260 | |
| Not Available |
| Full Name | Kendall Parsons |
|---|---|
| Gender | Female |
| Speciality | Advanced Practice Midwife |
| Location | 7556 Teague Rd Ste 430, Hanover, Maryland |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1780316448 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367A00000X | Advanced Practice Midwife | (Maryland) | Primary |
| Entity Name | University Of Maryland Community Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477530624 PECOS PAC ID: 3678472214 Enrollment ID: O20040102000687 |
News Archive
Hold the rose-coloured glasses: toddlers understand much more about false beliefs than parents and scientists previously suspected. A Canada-U.S. research team has discovered that very young children absolutely comprehend that other people believe things that aren't true.
A third dose of the Pfizer-BioNTech vaccine significantly increased neutralizing antibody levels against SARS-CoV-2, the virus that causes COVID-19, according to new research published in the New England Journal of Medicine.
PharmAthene, Inc., a biodefense company developing medical countermeasures against biological and chemical threats, today announced Phase I clinical trial results for Protexia, a pegylated recombinant version of human butyrylcholinesterase (rBChE), which has been shown to be effective in animal models in preventing toxicity from exposure to chemical nerve agents.
Many studies on the containment of the ongoing COVID-19 pandemic have dealt with the possible role of wastewater in predicting and detecting future outbreaks and understanding the epidemiology of COVID-19 disease. A recent study published on the preprint server medRxiv* in September 2020 shows that solid waste in sewage is a better substrate for testing than influent.
Life Technologies Corporation today debuted the life science industry's first benchtop sample preparation system designed to increase productivity while eliminating manual and contamination-related challenges traditionally associated with protein and epigenetic protocols. The Invitrogen MAGic™ Sample Processor enables researchers to cut protocol time in half, dramatically reduce experimental errors, and perform technically challenging experiments in protein purification and epigenetics.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kendall Parsons, CNM 7556 Teague Rd Ste 430, Hanover, MD 21076-1968 Ph: (410) 553-8260 | Kendall Parsons, CNM 7556 Teague Rd Ste 430, Hanover, MD 21076-1968 Ph: (410) 553-8260 |
News Archive
Hold the rose-coloured glasses: toddlers understand much more about false beliefs than parents and scientists previously suspected. A Canada-U.S. research team has discovered that very young children absolutely comprehend that other people believe things that aren't true.
A third dose of the Pfizer-BioNTech vaccine significantly increased neutralizing antibody levels against SARS-CoV-2, the virus that causes COVID-19, according to new research published in the New England Journal of Medicine.
PharmAthene, Inc., a biodefense company developing medical countermeasures against biological and chemical threats, today announced Phase I clinical trial results for Protexia, a pegylated recombinant version of human butyrylcholinesterase (rBChE), which has been shown to be effective in animal models in preventing toxicity from exposure to chemical nerve agents.
Many studies on the containment of the ongoing COVID-19 pandemic have dealt with the possible role of wastewater in predicting and detecting future outbreaks and understanding the epidemiology of COVID-19 disease. A recent study published on the preprint server medRxiv* in September 2020 shows that solid waste in sewage is a better substrate for testing than influent.
Life Technologies Corporation today debuted the life science industry's first benchtop sample preparation system designed to increase productivity while eliminating manual and contamination-related challenges traditionally associated with protein and epigenetic protocols. The Invitrogen MAGic™ Sample Processor enables researchers to cut protocol time in half, dramatically reduce experimental errors, and perform technically challenging experiments in protein purification and epigenetics.
› Verified 7 days ago
Marissa Lindsay Stear, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 7556 Teague Rd Ste 430, Hanover, MD 21076 Phone: 410-553-8260 |